beta
CASC
Cascadian Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Cascadian Therapeutics Inc is a clinical-stage biopharmaceutical company focusing in developing innovative therapeutic product candidates for the treatment of cancer.
Market Cap: 249 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.cascadianrx.com
Shares Outstanding: 50.6 Million
Float: 45.6 Million
Dividend: 0.0 (0.0%)
Beta: 2.583902
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 705 trading days
From: 2015-06-05 To: 2018-03-09
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-11-29 | 6.0 | 1.0 | 6.0 |